受强制性开放获取政策约束的文章 - Ysebaert Loic了解详情
无法在其他位置公开访问的文章：5 篇
Efficacy and safety of idelalisib in combination with ofatumumab for previously treated chronic lymphocytic leukaemia: an open-label, randomised phase 3 trial
JA Jones, T Robak, JR Brown, FT Awan, X Badoux, S Coutre, ...
The Lancet Haematology 4 (3), e114-e126, 2017
强制性开放获取政策： Lymphoma Research Foundation, USA
Romidepsin plus CHOP versus CHOP in patients with previously untreated peripheral T-cell lymphoma: results of the Ro-CHOP phase III study (conducted by LYSA)
E Bachy, V Camus, C Thieblemont, D Sibon, RO Casasnovas, L Ysebaert, ...
Journal of Clinical Oncology 40 (3), 242-251, 2022
强制性开放获取政策： Austrian Science Fund
Involvement of the Syk–mTOR pathway in follicular lymphoma cell invasion and angiogenesis
S Fruchon, S Kheirallah, T Al Saati, L Ysebaert, C Laurent, L Leseux, ...
Leukemia 26 (4), 795-805, 2012
强制性开放获取政策： National Institute of Health and Medical Research, France
Targeting kinases in cancer therapies: adverse effects on blood platelets
M Levade, S Severin, MP Gratacap, L Ysebaert, B Payrastre
Current Pharmaceutical Design 22 (16), 2315-2322, 2016
强制性开放获取政策： National Institute of Health and Medical Research, France
REALMA: Subset of patients with Marginal Zone Lymphomas from the French nationwide REALYSA real‐world prospective cohort.
C Bommier, M Donzel, C Rossi, L Fornecker, F Bijou, A Chauchet, ...
Hematological Oncology 41, 2023
强制性开放获取政策： National Institute of Health and Medical Research, France
可在其他位置公开访问的文章：60 篇
Rituximab plus lenalidomide in advanced untreated follicular lymphoma
F Morschhauser, NH Fowler, P Feugier, R Bouabdallah, H Tilly, ...
New England Journal of Medicine 379 (10), 934-947, 2018
强制性开放获取政策： US National Institutes of Health, National Institute of Health and Medical …
Ibrutinib treatment affects collagen and von Willebrand factor-dependent platelet functions
M Levade, E David, C Garcia, PA Laurent, S Cadot, AS Michallet, ...
Blood, The Journal of the American Society of Hematology 124 (26), 3991-3995, 2014
强制性开放获取政策： National Institute of Health and Medical Research, France
Bromohydrin pyrophosphate enhances antibody-dependent cell-mediated cytotoxicity induced by therapeutic antibodies
J Gertner-Dardenne, C Bonnafous, C Bezombes, AH Capietto, ...
Blood, The Journal of the American Society of Hematology 113 (20), 4875-4884, 2009
强制性开放获取政策： National Institute of Health and Medical Research, France
Single-cell RNA sequencing unveils the shared and the distinct cytotoxic hallmarks of human TCRVδ1 and TCRVδ2 γδ T lymphocytes
G Pizzolato, H Kaminski, M Tosolini, DM Franchini, F Pont, F Martins, ...
Proceedings of the National Academy of Sciences 116 (24), 11906-11915, 2019
强制性开放获取政策： National Institute of Health and Medical Research, France
Presence of multiple recurrent mutations confers poor trial outcome of relapsed/refractory CLL
R Guièze, P Robbe, R Clifford, S De Guibert, B Pereira, A Timbs, ...
Blood, The Journal of the American Society of Hematology 126 (18), 2110-2117, 2015
强制性开放获取政策： National Institute for Health Research, UK, Wellcome Trust, Swiss Cancer League
Several immune escape patterns in non-Hodgkin's lymphomas
C Laurent, K Charmpi, P Gravelle, M Tosolini, C Franchet, L Ysebaert, ...
Oncoimmunology 4 (8), e1026530, 2015
强制性开放获取政策： National Institute of Health and Medical Research, France
Phase 1b study of venetoclax-obinutuzumab in previously untreated and relapsed/refractory chronic lymphocytic leukemia
IW Flinn, JG Gribben, MJS Dyer, W Wierda, MB Maris, RR Furman, ...
Blood, The Journal of the American Society of Hematology 133 (26), 2765-2775, 2019
强制性开放获取政策： Cancer Research UK, UK Medical Research Council
Genomic arrays identify high-risk chronic lymphocytic leukemia with genomic complexity: a multicenter study
AC Leeksma, P Baliakas, T Moysiadis, A Puiggros, K Plevova, ...
haematologica 106 (1), 87, 2021
强制性开放获取政策： Knut and Alice Wallenberg Foundation, Swedish Research Council, Blood Cancer …
Boosting γδ T cell-mediated antibody-dependent cellular cytotoxicity by PD-1 blockade in follicular lymphoma
C Rossi, P Gravelle, E Decaup, J Bordenave, M Poupot, M Tosolini, ...
Oncoimmunology 8 (3), 1554175, 2019
强制性开放获取政策： National Institute of Health and Medical Research, France, Agence Nationale …
Immune recovery after fludarabine–cyclophosphamide–rituximab treatment in B-chronic lymphocytic leukemia: implication for maintenance immunotherapy
L Ysebaert, E Gross, E Kühlein, A Blanc, J Corre, JJ Fournié, G Laurent, ...
Leukemia 24 (7), 1310-1316, 2010
强制性开放获取政策： National Institute of Health and Medical Research, France
A New α5β1 Integrin-Dependent Survival Pathway Through GSK3β Activation in Leukemic Cells
F De Toni-Costes, M Despeaux, J Bertrand, E Bourogaa, L Ysebaert, ...
PloS one 5 (3), e9807, 2010
强制性开放获取政策： National Institute of Health and Medical Research, France
Differences and similarities in the effects of ibrutinib and acalabrutinib on platelet functions
J Series, C Garcia, M Levade, J Viaud, P Sié, L Ysebaert, B Payrastre
Haematologica 104 (11), 2292, 2019
强制性开放获取政策： National Institute of Health and Medical Research, France
Nurse-like cells impact on disease progression in chronic lymphocytic leukemia
F Boissard, C Laurent, AG Ramsay, A Quillet-Mary, JJ Fournie, M Poupot, ...
Blood cancer journal 6 (1), e381-e381, 2016
强制性开放获取政策： National Institute of Health and Medical Research, France
BTK and PLCG2 remain unmutated in one-third of patients with CLL relapsing on ibrutinib
S Bonfiglio, LA Sutton, V Ljungström, A Capasso, T Pandzic, S Weström, ...
Blood advances 7 (12), 2794-2806, 2023
强制性开放获取政策： Knut and Alice Wallenberg Foundation, Swedish Research Council, Cancer …
A phase 2 study of rituximab, bendamustine, bortezomib and dexamethasone for first-line treatment of older patients with mantle cell lymphoma
R Gressin, N Daguindau, A Tempescul, A Moreau, S Carras, ...
Haematologica 104 (1), 138, 2019
强制性开放获取政策： National Institute of Health and Medical Research, France
出版信息和资助信息由计算机程序自动确定